“Collaborative Excellence: A Testament to our Shared Success with Innovaderm!” – A Ventyx Biosciences Testimonial
Innovaderm is excited to share a glowing testimonial from Ventyx Biosciences! “We would like to express our gratitude for the exceptional partnership weâve had with Innovaderm. Our collaboration on a phase 2 study for moderate to severe plaque psoriasis was nothing short of remarkable. The expertise and motivation Innovaderm brought to the table were pivotal […]
Durability of Response to Icotrokinra in Adults With Moderate-to-Severe Plaque Psoriasis: One-Year Results From the Phase 3, Placebo- and Active Comparator-Controlled ICONIC-ADVANCE 1 & ICONIC-ADVANCE 2 Trials
Authors: Linda Stein Gold, April W Armstrong, Jennifer Soung, Ronald B Vender, Ălvaro GonzĂĄlez Cantero, Matthias Hoffmann, Scott T Guenthner, H Chih-Ho Hong, Dedee F Murrell, Eingun James Song, Leon Kircik, Matthias Augustin, Maxwell Sauder, Sascha Gerdes, Ofelia Reyes-Servin, Bassey Effiom Edem, Jennifer Campbell, Kellen Cresswell, Lea Kephart, Shu Li, Ya-Wen Yang, Robert Bissonnette Read […]
Navigating Phase 3 Clinical Trials: A Project Managerâs Guide
Navigating the complexities of phase 3 clinical trials is crucial for bringing new therapies to market. These trials are the final hurdle before approval and commercialization, making their successful execution essential for delivering innovative treatments to patients. The methodology behind these phase 3 trials includes key findings, discussing their implications, and offering recommendations for future […]
Plaque Psoriasis Case Study
Click here for a PDF version of this case study Outcomes Indero successfully managed this plaque psoriasis study and this resulted in: Enrollment completion 5 months earlier than planned Study Characteristics Study Phase: II Patient Population: Plaque Psoriasis IP Route of Administration: Systemic Total Enrollment: 224 patients, 59 sites (North America & Europe)â […]
Nimbus Testimonial
Innovaderm is proud of its partnership with Nimbus Therapeutics for an investigational oral TYK2 inhibitor, in a Phase 2b trial for patients with moderate-to-severe psoriasis. Innovadermâs reputed teams once again proved their expertise throughout the whole project, from the study design all the way to the trial reports, under tight timelines. âThere are many CRO […]
Episode 8: Mounia LahjouâPhase 3 Studies in Dermatology: What to Watch for?
Episode Notes Resources: [email protected]: Use this email to let us know what you want to hear about. Mounia Lahjou, Project Direct at Innovaderm has more than 17 years of experience in the industry. With her extensive skills and experience in the pharmaceutical industry, Mounia has made significant strides in the field. She is a disciplined […]
